Trace amounts of anti-A and anti-B isoagglutinins in plasmaderived immunoglobulin (Ig) have been associated with increased patient risk for hemolysis, a serious and sometimes fatal complication.
Eshmuno® P anti-A and Eshmuno® P anti-B are two distinct affinity based chromatography resins specifically designed to effectively remove anti-A and anti-B isoagglutinins, respectively.
- Reduced patient risks
- Improved economics
- Operational flexibility
- Improved quality control